The match didn’t cause a “mismatch of supply and demand” but did reveal an opportunity to create change, experts say.
The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.
Understanding the athlete heart in light of normal aging and CV risk requires a nuanced look at imaging findings, the paper ...
The vast majority of what we do would be eliminated if people fix their diet,” says cardiologist Kim Allan Williams Sr.
It’s not yet known whether a fibroid diagnosis could enhance risk stratification or how best to prevent ASCVD in these ...
Thomas Crawford meets with C. Michael Gibson to discuss the role of reconditioned pacemakers in low- and middle-income ...
Survival, quality of life, and efficacy remained similar in the 3 years after TAVI for patients with versus without blockages ...
Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...
Uncertainties about efficacy and longer-term safety with the Ventura interatrial shunt system (V-Wave, a Johnson & Johnson company) doomed the technology when vetted by a US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback